Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evaluation of regorafenib in colorectal cancer and GIST.

× No keyword cloud information.

10 in total

1. KIT Signaling Promotes Growth of Colon Xenograft Tumors in Mice and Is Up-Regulated in a Subset of Human Colon Cancers.

Authors: Evan C Chen; Taylor A Karl; Tomer Kalisky; Santosh K Gupta; Catherine A O'Brien; Teri A Longacre; Matt van de Rijn; Stephen R Quake; Michael F Clarke; Michael E Rothenberg
Journal: Gastroenterology Date: 2015-05-28 Impact factor: 22.682

2. Advances in 3D Vascularized Tumor-on-a-Chip Technology.

Authors: Sangmin Jung; Hyeonsu Jo; Sujin Hyung; Noo Li Jeon
Journal: Adv Exp Med Biol Date: 2022 Impact factor: 3.650

Review 3. Management of regorafenib-related toxicities: a review.

Authors: Saravanan K Krishnamoorthy; Valerie Relias; Sunit Sebastian; Vijay Jayaraman; Muhammad Wasif Saif
Journal: Therap Adv Gastroenterol Date: 2015-09 Impact factor: 4.409

4. Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib.

Authors: Potjana Jitawatanarat; Wen Wee
Journal: J Gastrointest Oncol Date: 2013-06

Review 5. An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma.

Authors: Pattaya Seeree; Phorutai Pearngam; Supeecha Kumkate; Tavan Janvilisri
Journal: Int J Genomics Date: 2015-09-02 Impact factor: 2.326

6. IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines.

Authors: Maria Grazia Refolo; Rosalba D'Alessandro; Catia Lippolis; Nicola Carella; Aldo Cavallini; Caterina Messa; Brian Irving Carr
Journal: Oncotarget Date: 2017-09-30

7. Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and Motility.

Authors: Rosalba D'Alessandro; Maria Grazia Refolo; Palma Aurelia Iacovazzi; Pasqua Letizia Pesole; Caterina Messa; Brian Irving Carr
Journal: Cancers (Basel) Date: 2019-06-07 Impact factor: 6.639

8. Cyclodextrin-based host-guest complexes loaded with regorafenib for colorectal cancer treatment.

Authors: Hongzhen Bai; Jianwei Wang; Chi Uyen Phan; Qi Chen; Xiurong Hu; Guoqiang Shao; Jun Zhou; Lihua Lai; Guping Tang
Journal: Nat Commun Date: 2021-02-03 Impact factor: 14.919

9. Critical appraisal of the use of regorafenib in the management of colorectal cancer.

Authors: Lucia Festino; Alessio Fabozzi; Anna Manzo; Valentina Gambardella; Erika Martinelli; Teresa Troiani; Ferdinando De Vita; Michele Orditura; Fortunato Ciardiello; Floriana Morgillo
Journal: Cancer Manag Res Date: 2013-04-12 Impact factor: 3.989

10. Molecular Modeling Study of c-KIT/PDGFRα Dual Inhibitors for the Treatment of Gastrointestinal Stromal Tumors.

Authors: Seketoulie Keretsu; Suparna Ghosh; Seung Joo Cho
Journal: Int J Mol Sci Date: 2020-11-03 Impact factor: 5.923

10 in total